VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $2,003,000 | -45.6% | 86,200 | -62.7% | 0.16% | -54.6% |
Q1 2018 | $3,682,000 | +59.9% | 231,276 | +108.8% | 0.35% | +13.7% |
Q4 2017 | $2,302,000 | +99.5% | 110,787 | +37.6% | 0.31% | +46.4% |
Q3 2017 | $1,154,000 | -60.7% | 80,510 | -52.6% | 0.21% | -51.7% |
Q2 2017 | $2,939,000 | +796.0% | 169,892 | +472.1% | 0.43% | +312.4% |
Q1 2017 | $328,000 | -59.5% | 29,697 | -10.0% | 0.10% | +12.9% |
Q3 2016 | $810,000 | -74.3% | 33,000 | -78.9% | 0.09% | -33.1% |
Q2 2016 | $3,148,000 | -49.8% | 156,289 | +141.4% | 0.14% | -43.5% |
Q1 2016 | $6,273,000 | -16.3% | 64,751 | +8685.8% | 0.25% | +5.1% |
Q4 2015 | $7,492,000 | +414.6% | 737 | -88.8% | 0.23% | +766.7% |
Q2 2015 | $1,456,000 | +1.8% | 6,553 | -9.0% | 0.03% | -41.3% |
Q1 2015 | $1,430,000 | +81.5% | 7,200 | +30.9% | 0.05% | +142.1% |
Q4 2014 | $788,000 | -16.3% | 5,500 | -23.4% | 0.02% | -36.7% |
Q3 2014 | $942,000 | – | 7,179 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |